INSMED Inc Financial Ratios
INSM / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -2.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-172.8%
Profit Margin
-210.5%
Net Income / Revenue
Asset Turnover
0.27
Revenue / Total Assets
Equity Multiplier
3.06
Total Assets / Equity
Composite: -172.8% (reported: -172.8%)
Profitability
Liquidity
Current Ratio
3.83
Quick Ratio
3.54
Solvency
Interest Coverage
-11.16
Efficiency
Asset Turnover
0.27
Inventory Turnover
0.93
Days Sales Outstanding
85 days
As of FY2025 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-15.9%
-4.6pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.